Sensitivity and specificity of nuclear medicines (DTPA and DMSA) with magnetic resonance imaging in diagnosing bone metastasis.
Shoaa G ShetewiJaber H AlyamiBander S Al MutairiSaeed M BafarajPublished in: Nuclear medicine review. Central & Eastern Europe (2022)
The results conclude that MRI provided favorable diagnostic performance for bone metastasis. It emphasizes that diagnosis using MRI may enable practitioners to devise optimal carcinoma treatment strategies. The healthcare practitioners need to assess the MRI findings to determine improved treatment plans.